Literature DB >> 11895619

T cells and effector mechanisms in the pathogenesis of atopic dermatitis.

Mübeccel Akdis1, Axel Trautmann, Kurt Blaser, Cezmi A Akdis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11895619     DOI： 10.1007/s11882-002-0029-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN： 1529-7322            Impact factor:   4.806


× No keyword cloud information.
  33 in total

1.  IL-12 synthesis by human Langerhans cells.

Authors:  K Kang; M Kubin; K D Cooper; S R Lessin; G Trinchieri; A H Rook
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

2.  Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

Authors:  V A Varney; Q A Hamid; M Gaga; S Ying; M Jacobson; A J Frew; A B Kay; S R Durham
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

3.  Serum IgE in atopic dermatitis: relationship to severity of cutaneous involvement and course of disease as well as coexistence of atopic respiratory diseases.

Authors:  B Wüthrich
Journal:  Clin Allergy       Date:  1978-05

4.  Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis.

Authors:  M Akdis; H U Simon; L Weigl; O Kreyden; K Blaser; C A Akdis
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

5.  Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity.

Authors:  Y Shimada; S Sato; M Hasegawa; T F Tedder; K Takehara
Journal:  J Allergy Clin Immunol       Date:  1999-07       Impact factor: 10.793

6.  Immunoglobulin E response to human proteins in atopic patients.

Authors:  R Valenta; D Maurer; R Steiner; S Seiberler; W R Sperr; P Valent; S Spitzauer; S Kapiotis; J Smolen; G Stingl
Journal:  J Invest Dermatol       Date:  1996-08       Impact factor: 8.551

7.  Expression of endothelial-leukocyte adhesion molecule-1 in elicited late phase allergic reactions.

Authors:  D Y Leung; J S Pober; R S Cotran
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

8.  Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis.

Authors:  T Werfel; A Morita; M Grewe; H Renz; U Wahn; J Krutmann; A Kapp
Journal:  J Invest Dermatol       Date:  1996-12       Impact factor: 8.551

Review 9.  Autoallergy: a pathogenetic factor in atopic dermatitis?

Authors:  R Valenta; S Seiberler; S Natter; V Mahler; R Mossabeb; J Ring; G Stingl
Journal:  J Allergy Clin Immunol       Date:  2000-03       Impact factor: 10.793

10.  Human eosinophils produce biologically active IL-12: implications for control of T cell responses.

Authors:  M Grewe; W Czech; A Morita; T Werfel; M Klammer; A Kapp; T Ruzicka; E Schöpf; J Krutmann
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422
View more
  3 in total

Review 1.  Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Authors:  Katja Woidacki; Ana Claudia Zenclussen; Frank Siebenhaar
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

2.  Oral Administration of Liquiritigenin Confers Protection from Atopic Dermatitis through the Inhibition of T Cell Activation.

Authors:  Hyun-Su Lee; Eun-Nam Kim; Gil-Saeng Jeong
Journal:  Biomolecules       Date:  2020-05-19

3.  Oral Administration of p-Hydroxycinnamic Acid Attenuates Atopic Dermatitis by Downregulating Th1 and Th2 Cytokine Production and Keratinocyte Activation.

Authors:  Hyun-Su Lee; Eun-Ju Choi; Kyung-Sik Lee; Hye-Ran Kim; Bo-Ra Na; Min-Sung Kwon; Gil-Saeng Jeong; Hyun Gyu Choi; Eun Young Choi; Chang-Duk Jun
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.